Gimv
Overview
Gimv is a European investment company that partners with entrepreneurial and innovative companies through its strategic investment platforms: Consumer, Healthcare, Smart Industries, and Sustainable Cities.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Exciva GmbH | Jan 2026 | Series B | Lead |
| Kinaset Therapeutics | Jan 2026 | Series B | Co-investor |
| Mediar Therapeutics | Jan 2026 | Series B | Co-investor |
| Spineart | Sep 2025 | Early Funding | Co-investor |
| Alpine Hearing Protection | Jul 2025 | Buyout/LBO | Lead |
Key People
Bart Troubleyn
Managing Partner At Gimv Head Anchor Investments
Bram Vanparys
Managing Partner-Head Of Life Sciences
Koen Bouckaert
Managing Partner - Gimv Consumer Member Of The Executive Team And Investment Committee
Andreas Jurgeit
Partner
David De Peuter
Partner
Gautier Lefebvre
Partner - Healthcare
Guillaume Bardy
Partner
Maja Markovic
Partner
Michaël Vlemmix
Partner - Life Sciences (Portfolio Manager)
Patrick Franken
Partner at Gimv Consumer Private Equity
Philipp von Hammerstein
Partner
Ronald Bartel
Partner Smart Industries
Ruben Monballieu
Partner
Hilde Windels
Member Board of Directors
Catharina Soenen
Principal - Sustainable Cities
Ferdinand Becker
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
